ACNE INVERSA

Clinical trials for ACNE INVERSA explained in plain language.

Never miss a new study

Get alerted when new ACNE INVERSA trials appear

Sign up with your email to follow new studies for ACNE INVERSA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Can anifrolumab calm the painful boils of HS? a new trial seeks answers.

Disease control Completed

This study tests whether anifrolumab, an antibody drug, can reduce skin abscesses and nodules in people with hidradenitis suppurativa (HS). Fifteen adults with moderate-to-severe HS will receive the drug intravenously over 24 weeks. The main goal is to see if at least half of par…

Matched conditions: ACNE INVERSA

Phase: PHASE2 • Sponsor: University of North Carolina, Chapel Hill • Aim: Disease control

Last updated Aug 05, 2026 00:00 UTC

ACNE INVERSA

Get alerted when new ACNE INVERSA trials appear

Can anifrolumab calm the painful boils of HS? a new trial seeks answers.